(19)
(11) EP 2 632 448 A1

(12)

(43) Date of publication:
04.09.2013 Bulletin 2013/36

(21) Application number: 11837235.8

(22) Date of filing: 28.10.2011
(51) International Patent Classification (IPC): 
A61K 31/122(2006.01)
(86) International application number:
PCT/US2011/058477
(87) International publication number:
WO 2012/058649 (03.05.2012 Gazette 2012/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 15.07.2011 US 201161508434 P
30.10.2010 US 408572 P
01.03.2011 US 201161448150 P

(71) Applicants:
  • KinDex Therapeutics, LLC
    Seattle, WA 98104 (US)
  • Carroll, Brian
    Gig Harbor, WA 98329 (US)
  • Darland, Gary
    Port Orchard, WA 98367 (US)
  • Desai, Anuradha
    Gig Harbor, WA 98335 (US)
  • Konda, Veera
    Gig Harbor, WA 98335 (US)
  • Dahlberg, Clinton J.
    Port Orchard, WA 98367 (US)
  • Urban, Jan
    Gig Harbor, WA 98335 (US)

(72) Inventors:
  • CARROLL, Brian
    WA 98329 (US)
  • DARLAND, Gary
    WA 98367 (US)
  • DESAI, Anuradha
    WA 98335 (US)
  • KONDA, Veera
    WA 98335 (US)
  • DAHLBERG, Clinton, J.
    WA 98367 (US)
  • URBAN, Jan
    WA 98335 (US)

(74) Representative: Williams, Richard Andrew Norman 
Harrison Goddard Foote LLP 140 London Wall
London EC2Y 5DN
London EC2Y 5DN (GB)

   


(54) CIS 3,4-DIHYDROXY-2-(3-METHYLBUTANOYL)-5-(-3-METHYLBUTYL)-4-(4-METHYLPENTANOYL)CYCLOPENT-2-EN-1-ONE DERIVATIVES, SUBSTANTIALLY ENANTIOMERICALLY PURE COMPOSITIONS AND METHODS